European rating of drug harms

  title={European rating of drug harms},
  author={Jan G.C. van Amsterdam and David J. Nutt and Lawrence D. Phillips and Wim van den Brink},
  journal={Journal of Psychopharmacology},
  pages={655 - 660}
Background: The present paper describes the results of a rating study performed by a group of European Union (EU) drug experts using the multi-criteria decision analysis model for evaluating drug harms. Methods: Forty drug experts from throughout the EU scored 20 drugs on 16 harm criteria. The expert group also assessed criteria weights that would apply, on average, across the EU. Weighted averages of the scores provided a single, overall weighted harm score (range: 0–100) for each drug… 

Figures and Tables from this paper

The Australian drug harms ranking study
Overall, alcohol was the most harmful drug when harm to users and harm to others was combined, followed by cigarettes, crystal methamphetamine, cannabis, heroin and pharmaceutical opioids.
Ranking the harm of non-medically used prescription opioids in the UK.
Updated Indicators to Evaluate Harmful Drug Use, in Particular, Poly-Drug Use.
It is shown that high values of poly-drug use indicators are linked to specific behaviours related to interest in school, relationship with parents and use of leisure time, consistent with previous analyses based on surveys among high school students in Italy.
Toward an Improved Multi-Criteria Drug Harm Assessment Process and Evidence-Based Drug Policies
The paper concludes with outlines of substance subset-specific extensions of the MCDHS and related policy proposals in the four areas identified as generating the most controversy: non-medical use of opioids, “study aid” uses of stimulants, shifting trends in nicotine containing products, and regulation of medical and recreational uses of cannabis.
Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts
In Germany, alcohol and illicit drugs (including new psychoactive substances) continue to rank among the most harmful addictive substances in contrast to prescribed agents including opioid analgesics and NOAs, and current laws are incongruent with these harm rankings.
Assessing the European impact of alcohol misuse and illicit drug dependence research: clinical practice guidelines and evidence-base policy
The volume of research on illicit drug addiction is commensurate to the European burden, whereas alcohol misuse is far below what is needed to curb a significant source of harm.
Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis
Background: Ecstasy (3,4-methylenedioxymethamphetamine (MDMA)) has a relatively low harm and low dependence liability but is scheduled on List I of the Dutch Opium Act (‘hard drugs’). Concerns
Using the pharmacy retail model to examine perceptions and biases of a UK population sample towards regulation of specific psychoactive drugs
A majority of the male participants concluded that being legally permitted to consume alcohol, tobacco, cannabis and Psilocybe mushrooms is a human right in contrast to the majority of female participants who solely considered alcohol consumption to be a humanright.


Drug harms in the UK: a multicriteria decision analysis
Ranking the Harm of Alcohol, Tobacco and Illicit Drugs for the Individual and the Population
Whether the legal classification of drugs in the Netherlands corresponds with the ranking of the drugs according to their science-based ranking of harm based on the scientific state of the art is evaluated.
The high harm score of alcohol. Time for drug policy to be revisited
Policy measures should, in addition to regulatory measures to reduce alcohol use, aim at closing the treatment gap and improving treatment effectiveness of people with an alcohol use disorder, according to the key message.
Basing drug scheduling decisions on scientific ranking of harmfulness: false promise from false premises.
It is suggested that multiple dimensions of harm need to be displayed to inform human judgments of what drugs should be scheduled and not just a single measure of harmfulness.
Advances in decision analysis : from foundations to applications
The Foundations of Decision Analysis Revisited and A Personal Account of How It Got Started and Evolved are presented.
Decision conferencing
  • 2007